|
On 05-feb-2026, chamberlain technologies became aware of a complaint involving a previously implanted surgimesh xb device.The device had been implanted on (b)(6) 2022.During a subsequent surgical procedure, the surgeon observed tissue adhesion involving the silicone-coated surface of the mesh.A portion of the mesh was surgically excised.The remaining portion of the device remained implanted.No patient impact.The device was not returned for evaluation.A review of the device history record for the reported lot has been initiated.No additional clinical details have been provided to date.Investigation remains ongoing.
|